Drawing for CENDUIT

USPTO serial 77186201

CENDUIT

Reviewed by CopyMark Law Group

Reg. 3595533Status 800Registered
Filing date
Status date
Registration date
Mar 24, 2009
Examiner
ESTRADA, LINDA M
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with CENDUIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arlene D. Hanks

Arlene D. Hanks Moore & Van Allen PLLC100 North Tryon StreetCharlotte, NC 28202-4003UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Supply chain management services for the clinical trials of others, namely, managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, supply and demand forecasting and product distribution processes for others for clinical trials through the use of interactive voice response (IVR) systems, web interfaces, facsimile and electronic data collection technologies; data processing for clinical investigators and clients in the pharmaceutical and biotechnology industries in the fields of clinical trials and clinical trial supply chain management via interactive voice response (IVR) systems, web interfaces and facsimileACTIVE—
042Providing clinical trial development services through the use of interactive voice response (IVR) systems, web interfaces, facsimile and electronic data collection technologies, providing analysis of clinical trial data provided to and for clinical investigators and clients in the pharmaceutical and biotechnology industries in the fields of clinical trials and clinical trial supply chain management via interactive voice response (IVR) systems, web interfaces, facsimile, and electronic data collection technologiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 24, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 24, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 24, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 24, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 19, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 19, 2019NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Apr 19, 2019RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Apr 19, 201989AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Apr 19, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 18, 2019E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 24, 2018REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Apr 23, 2015NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 23, 2015C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 23, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 10, 2015E815TEAS SECTION 8 & 15 RECEIVED—
Apr 6, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 17, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 24, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 17, 2009REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Feb 14, 2009CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 4, 2009SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 4, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 16, 2009IUAFUSE AMENDMENT FILED—
Jan 16, 2009EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 23, 2008ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 22, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 29, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 9, 2008NPUBNOTICE OF PUBLICATION—
Mar 25, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 25, 2008ALIEASSIGNED TO LIE—
Mar 11, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 16, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 15, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 15, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 1, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2007DOCKASSIGNED TO EXAMINER—
May 24, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance